Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Delayed Quote. Delayed  - 09/29 05:35:13 pm
88.3 EUR   -1.08%
09/29 BAYER : Not intended for UK Media -- Bayer and DelSiTech Partner to ..
09/28 Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/28 MONSANTO : Too early to speculate on job consolidation in Soda Sprin..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : Bayer CropScience Expands Research and Development Cooperation with Nature Source Genetics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/14/2013 | 03:33pm CEST

Bayer%20CropScience%20Expands%20Research%20and%20Development%20Cooperation%20with%20Nature%20Source%20Genetics%20');openNewWindow('../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download',500,525,0,0,'scrollbars=yes,resizable=yes,statusbar=no');return false;" href="../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download" sizset="false" sizcache02840271716677351="0.0.10"downloadSoybean plants

Monheim (Germany) and Ithaca (USA), March 14, 2013- Bayer CropScience and the research company Nature Source Genetics, based in Ithaca, New York, USA, have signed an agreement to expand their already fruitful cooperation. They have entered into a five-year collaboration involving the pre-breeding and enhancement of soybean germplasm. The goal is to create improved seed by making use of innovative technologies to identify and incorporate previously non detectable, naturally occurring genes. Financial terms have not been disclosed.

The partnership will combine the expertise of Bayer CropScience's soybean breeders and geneticists with Nature Source Genetics' technical know-how and the company's bioanalytical platform to identify and utilize the full range of promising germplasm. The partnership also builds on a successful cotton partnership, which began in 2008.

"The collaboration between Bayer CropScience and Nature Source Genetics marks a significant expansion in the strategic scope of our soybean breeding program", said Mike Gilbert, Head of Global Breeding and Trait Development at Bayer CropScience. "With this partnership, we now have access to new and valuable sources of genetic diversity in soybeans, which we can incorporate into our already robust breeding program to further expand and improve the products we offer growers worldwide."

This agreement will provide Bayer CropScience researchers with the opportunity to identify high value genes in previously unused genetic material and incorporate these new genes into commercial germplasm.

"We are very pleased to be entering into this joint venture with Bayer CropScience for the genetic improvement of soy. Nature Source Genetics brings to this partnership unique expertise and proprietary algorithms developed within its bioanalytical platform encompassing diverse competencies from life and computational sciences," said Professor Steven D. Tanksley, CEO and Chief Scientific Officer of Nature Source Genetics. "These competencies will significantly expedite the identification and incorporation of new and useful genetic variation into Bayer CropScience's breeding material for the development of improved commercial varieties."

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission "Bayer: Science For A Better Life". Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world's leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

About Nature Source Genetics
Nature Source Genetics is a company based in Ithaca, New York co-founded in 2006 by Professor Steven D. Tanksley and Dr. Theresa M. Fulton from Cornell University with Dr. Vincent Pétiard, the former Head of Plant Sciences and Technology at Nestlé. Nature Source Genetics offers exclusive services on a crop per crop basis, and is currently working on different field crops, vegetables, and tropical crops with agro-seed and food companies to optimize the benefits of natural genetic diversity in target crops. Nature Source Genetics has also started to explore with animal breeding companies the opportunities of use of its computational genomics capabilities. More info at: www.naturesourcegenetics.com

Find more information at www.bayercropscience.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
09/29 BAYER : Federal Contracts Awarded by Federal Agencies in Minnesota (Sept. 29)
09/29 BAYER : $293,586 Federal Contract Awarded to Bayer Healthcare
09/29 BAYER : Not intended for UK Media -- Bayer and DelSiTech Partner to Develop Inno..
09/28 Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/28 MONSANTO : Too early to speculate on job consolidation in Soda Springs
09/28 Lupin, torrent zero in on bayer's biz
09/27 MARKSANS PHARMA : Gets usfda nod for allergy drug
09/26 NEW CLINICAL GUIDELINES : -- Iberogast™ recommended for the treatment of f..
09/26DJLanxess Shares Rise on Acquisition of Chemtura
09/25 POLITICAL NOTES : Garamendi sends condolences
More news
Sector news : Pharmaceuticals - NEC
09/29DJGLAXOSMITHKLINE : Appoints New Consumer Healthcare Chief
09/29DJNOVO NORDISK A/S : to Cut 1,000 Jobs Amid Growing Competition -- Update
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09/29 Foamix Spots Dermatology Opportunity
09/28 Enrollment underway in Bayer and Merck's large-scale study of vericiguat in h..
09/27 Disney Prepping Twitter Bid
09/26 Monsanto/Bayer Merger Difficult, But Could Send MON Higher
09/22 Biontech Deal Sees Roche Bet On mRNA
Advertisement
Financials (€)
Sales 2016 46 906 M
EBIT 2016 8 130 M
Net income 2016 4 791 M
Debt 2016 15 386 M
Yield 2016 2,99%
P/E ratio 2016 15,93
P/E ratio 2017 13,73
EV / Sales 2016 1,90x
EV / Sales 2017 1,76x
Capitalization 73 813 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 109 €
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-23.33%82 870
JOHNSON & JOHNSON16.23%326 636
ROCHE HOLDING LTD.-12.41%217 190
NOVARTIS AG-10.14%212 589
PFIZER INC.5.30%206 172
MERCK & CO., INC.19.84%175 038
More Results